SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-070942
Filing Date
2018-12-03
Accepted
2018-12-03 09:10:36
Documents
11
Period of Report
2018-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-40916_18k.htm 8-K 37938
2 EX-1.1 a18-40916_1ex1d1.htm EX-1.1 279407
3 EX-4.1 a18-40916_1ex4d1.htm EX-4.1 1493701
4 EX-10.1 a18-40916_1ex10d1.htm EX-10.1 290571
5 EX-10.2 a18-40916_1ex10d2.htm EX-10.2 216298
6 EX-10.3 a18-40916_1ex10d3.htm EX-10.3 152414
7 EX-10.4 a18-40916_1ex10d4.htm EX-10.4 122051
8 EX-10.5 a18-40916_1ex10d5.htm EX-10.5 246220
9 EX-10.6 a18-40916_1ex10d6.htm EX-10.6 181371
10 EX-99.1 a18-40916_1ex99d1.htm EX-99.1 18844
11 GRAPHIC g409161mmi001.jpg GRAPHIC 4406
  Complete submission text file 0001104659-18-070942.txt   3046222
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 181212911
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1